Stocks › TECH
BIO-TECHNE Corp
TECH·Nasdaq·
United States·USD
United States·USD$72.43
-0.15 (-0.21%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
TECH
BIO-TECHNE Corp · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
TECHS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of TECH by members of U.S. Congress · 65 on record · 10 in the last 12 months
Whale Activity
Position changes in TECH reported for 2026-06-30 by 20 tracked institutional filers
- Increased6
- New3
- Held0
- Decreased0
- Closed1
- No prior filing10
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 14.0M | $990.9M | increased |
| VANGUARD CAPITAL MANAGEMENT LLC | 10.2M | $721.9M | increased |
| HBK INVESTMENTS L P | 6.8M | $482.2M | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.5M | $459.7M | increased |
| Ruane, Cunniff & Goldfarb L.P. | 3.3M | $236.6M | — |
| SNYDER CAPITAL MANAGEMENT L P | 3.2M | $223.5M | — |
| MILLENNIUM MANAGEMENT LLC | 989.0K | $69.9M | new |
| CITADEL ADVISORS LLC | 965.9K | $68.2M | increased |
| TIG Advisors, LLC | 842.2K | $59.5M | — |
| ROYCE & ASSOCIATES LP | 789.7K | $55.8M | — |
| CRAMER ROSENTHAL MCGLYNN LLC | 774.7K | $54.7M | — |
| D. E. Shaw & Co., Inc. | 228.5K | $16.1M | new |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by TECH insiders, by quarter · Form 4
Recent Insider Transactions
837 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Crouse Steven C.President - Diag & Spatial Bi | Tax withholding | −216 | $49.77 | $11K | Jun 2, 2026 | Form 4 ↗ |
| Crouse Steven C.President - Diag & Spatial Bi | Option exercise | +600 | — | — | Jun 2, 2026 | Form 4 ↗ |
| Herr Amy E.Director | Sale | −6,636 | $48.28 | $320K | May 8, 2026 | Form 4 ↗ |
| Herr Amy E.Director | Option exercise | +6,636 | $47.60 | $316K | May 8, 2026 | Form 4 ↗ |
| Hippel JamesCFO | Tax withholding | −57.0K | $56.68 | $3.2M | May 5, 2026 | Form 4 ↗ |
| Hippel JamesCFO | Option exercise | +62.0K | $47.60 | $3.0M | May 5, 2026 | Form 4 ↗ |
| Bohnen ShaneSVP - General Counsel | Tax withholding | −7,055 | $56.68 | $400K | May 5, 2026 | Form 4 ↗ |
| Bohnen ShaneSVP - General Counsel | Option exercise | +8,400 | $47.60 | $400K | May 5, 2026 | Form 4 ↗ |
| Kelderman KimChief Executive Officer · Director | Tax withholding | −24.0K | $56.68 | $1.4M | May 5, 2026 | Form 4 ↗ |
| Kelderman KimChief Executive Officer · Director | Option exercise | +26.7K | $47.60 | $1.3M | May 5, 2026 | Form 4 ↗ |
| Crouse Steven C.President - Diag & Spatial Bi | Tax withholding | −311 | $55.02 | $17K | May 1, 2026 | Form 4 ↗ |
| Crouse Steven C.President - Diag & Spatial Bi | Option exercise | +794 | — | — | May 1, 2026 | Form 4 ↗ |
| Kelderman KimChief Executive Officer · Director | Tax withholding | −1,363 | $58.58 | $80K | Apr 22, 2026 | Form 4 ↗ |
| Kelderman KimChief Executive Officer · Director | Option exercise | +11.3K | $0.00 | $0 | Apr 22, 2026 | Form 4 ↗ |
| Hippel JamesCFO | Tax withholding | −56.1K | $58.58 | $3.3M | Apr 22, 2026 | Form 4 ↗ |
| Hippel JamesCFO | Option exercise | +62.0K | $0.00 | $0 | Apr 22, 2026 | Form 4 ↗ |
| Kelderman KimChief Executive Officer · Director | Tax withholding | −32.1K | $58.66 | $1.9M | Apr 14, 2026 | Form 4 ↗ |
| Kelderman KimChief Executive Officer · Director | Option exercise | +36.5K | $0.00 | $0 | Apr 14, 2026 | Form 4 ↗ |
| Bohnen ShaneSVP - General Counsel | Tax withholding | −740 | $53.13 | $39K | Apr 3, 2026 | Form 4 ↗ |
| Bohnen ShaneSVP - General Counsel | Option exercise | +2,259 | $0.00 | $0 | Apr 3, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding TECH · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| Fidelity Contrafund | 5.0M | $352.5M | 0.20% | Jun 30, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 5.0M | $351.1M | 0.02% | Jun 30, 2026 |
| VANGUARD 500 INDEX FUND VANGUARD INDEX FUNDS | 4.1M | $286.6M | 0.02% | Jun 30, 2026 |
| Invesco S&P 500 Equal Weight ETF Invesco Exchange-Traded Fund Trust | 3.6M | $255.9M | 0.27% | Jul 31, 2026 |
| SMALLCAP World Fund Inc | 3.6M | $253.9M | 0.27% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 3.6M | $253.4M | 0.13% | Jun 30, 2026 |
| Eaton Vance Atlanta Capital SMID-Cap Fund Eaton Vance Growth Trust | 2.6M | $184.0M | 2.09% | Jun 30, 2026 |
| iShares Core S&P 500 ETF iShares Trust | 2.2M | $152.6M | 0.02% | Jun 30, 2026 |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 2.1M | $146.3M | 0.31% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P 500(R) ETF Trust | 1.9M | $134.3M | 0.02% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list TECH's shares (CUSIP 09073M104), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 12.8M shares8.1%
Aug 6, 2026 · ↗ - FMR LLCSCHEDULE 13G/A · passive (13G) · 12.8M shares8.1%
Aug 6, 2026 · ↗ - Abigail P. JohnsonSCHEDULE 13G · passive (13G) · 7.9M shares5.0%
May 6, 2026 · ↗ - FMR LLCSCHEDULE 13G · passive (13G) · 7.9M shares5.0%
May 6, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming bio techne as client
- SQUIRE PATTON BOGGSBIO-TECHNE CORPORATION · 2026 Q2—
Filing ↗ - SQUIRE PATTON BOGGSBIO-TECHNE CORPORATION · 2026 Q1 · AGR—
Filing ↗ - SQUIRE PATTON BOGGSBIO-TECHNE CORPORATION · 2025 Q4—
Filing ↗ - SQUIRE PATTON BOGGSBIO-TECHNE CORPORATION · 2025 Q3 · AGR—
Filing ↗ - SQUIRE PATTON BOGGSBIO-TECHNE CORPORATION · 2025 Q2—
Filing ↗
Government Contracts
Federal awards to bio techne · USAspending
$34KAwarded · 1 contract on record
- Department of Health and Human ServicesRECOMBINANT RAT LEPTIN PROTEIN, CF$34K
Sep 9, 2026 · ↗
U.S. Patents
Recent USPTO applications naming BIO-TECHNE Corp
No USPTO patent applications found for BIO-TECHNE Corp.
Annual Financials
From TECH's 10-K filings · XBRL
No annual XBRL figures on record for TECH. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
- 4-for-1Stock splitNov 30, 2022
- 2-for-1Stock splitDec 4, 2000
- 2-for-1Stock splitNov 18, 1997
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 5.07, 7.01, 9.01Shareholder vote · Reg FD disclosureSep 23, 2026
EDGAR ↗ - 8-K · Items 8.01Other eventsSep 14, 2026
EDGAR ↗ - 8-K · Items 2.02, 8.01, 9.01Results of operations · Other eventsAug 12, 2026
EDGAR ↗ - 8-K · Items 1.01, 5.02, 9.01Material agreement · Officer / director changeJun 26, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureJun 25, 2026
EDGAR ↗ - 8-K · Items 2.02, 8.01, 9.01Results of operations · Other eventsMay 6, 2026
EDGAR ↗
About BIO-TECHNE Corp
From SEC EDGAR company records
OVERVIEW Bio-Techne and its subsidiaries, collectively doing business as Bio-Techne Corporation (“Bio-Techne”, “we”, “our”, “us” or the “Company”), develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. Our broad product portfolio and application expertise enables scientific investigations into biological processes and molecular diagnostics, revealing the nature, diagnosis, etiology and progression of specific diseases. Our products aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. We manage the business in two operating segments – our Protein Sciences segmen…
Industry (SIC 2836)Biological Products, (No Diagnostic Substances)
SectorHealthcare
HeadquartersMINNEAPOLIS, MN
IncorporatedMN
SEC CIK0000842023 ↗
Former namesTECHNE CORP /MN/